Skip to main content

New and competing renewal awards for July 2018

Wednesday, August 8, 2018
McGovern-Davison Children's Health Center

The following are new and competing renewal awards made to faculty in the Department of Pediatrics through the month of July 2018. Please extend your congratulations to the following individuals.

Priya Kishnani (Medical Genetics) received an award from the Epivax, Inc. in the amount of $64,200 for a project entitled “GAA-iTEM: Personalizing the prediction of Anti-therapeutic Antibody Response in Pompe Disease Patients”.  The project period is 07/01/2018-06/30/2020.

Mai Elmallah (Pulmonary and Sleep Medicine) received an award from Vertex Pharmaceuticals in the amount of $13,669 for a project entitled “A Post-Approval Observational Study to Evaluate the Long-term Effectiveness and Safety of Orkambi in US Patients who Completed Study VX12-809-105 Part A“.  The project period is 06/21/18-04/30/2021.

David Van Mater (Hematology-Oncology) received an award from Boston Children’s Hospital in the amount of $1,037 for a project entitled “Visual Field Outcomes in Pediatric Patients with NF1-associated Optic Pathway Gliomas”.  The project period is 02/01/2018-01/31/2019.

Sallie Permar (Infectious Diseases), David Harpole (Cardiovascular and Thoracic Surgery), and Scott Palmer (Pulmonary, Allergy and Critical Care Medicine) received an award from the National Institutes of Health in the amount of $1,421,210 for a project entitled “Duke Resident Physician-Scientist Program-NIAID”.  The project period is 08/01/2018-07/31/2022.

Adam Bensimhon (Nephrology Fellow) [Mentors: Rasheed Gbadegesin (Nephrology) and Kevin Watt (Critical Care Medicine)] received an award from the Thrasher Research Fund (Early Career Award Program) in the amount of $26,750 for a project entitled “Pharmacokinetics of Cefepime in Children Receiving Continuous Renal Replacement Therapy”.  The project period is 07/16/2018-07/15/2019.

Gregory Crawford (Medical Genetics) received an award from the National Institutes of Health in the amount of $355,941 for a project entitled “3/3 Chromatin regulation during brain development and in ASD”. The project period is 08/01/2018-07/31/2019.

Muhammad Zafar (Neurology) received an award from UCB Pharma in the amount of $267,040 for a project entitled” A Multicenter, Open-label study to evaluate the Pharmacokinetics, Safety and tolerability of intravenous Brivaracetam in Subjects 1 month to <16 years of age with Epilepsy Phase 2”.  The project period is 07/03/2018-11/30/19.

Matthew Kelly (Infectious Diseases) received an award from Merck Sharp & Dohme in the amount of $138,158 for a project entitled” A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of a Single Infusion of Bezlotoxumab (MK-6072, Human Monoclonal Antibody to C. difficile Toxin B) in Children Aged 1 to <18 years receiving Antibacterial Drug Treatment for C. Difficile Infection”.  The project period is 07/03/2018-07/31/2022.

Congratulations to these faculty on their awards and best wishes to them in their investigative work.

Coleen K. Cunningham, MD
Vice Chair, Research
Professor of Pediatrics
Division of Infectious Diseases
Chief, Division of Global Health